Abpro Holdings (ABPO) Change in Acquisitions & Divestments (2022)
Abpro Holdings' (ABPO) quarterly Change in Acquisitions & Divestments came in at $331516.0 in Q4 2022.
Abpro Holdings (ABPO) Change in Acquisitions & Divestments (2022) Analysis & Trends
Abpro Holdings (ABPO) has 1 years of Change in Acquisitions & Divestments data on file, last reported at $331516.0 in Q4 2022.
- Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $331516.0 in Q4 2022, while the trailing twelve-month figure through Dec 2023 was $331516.0 (changed N/A YoY) and the FY2023 annual result came in at $2.1 million, up 543.19% from the prior year.
- Change in Acquisitions & Divestments held at $331516.0 in Q4 2022.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $331516.0 in Q4 2022 to a low of $331516.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Abpro Holdings | 1.14 Mn | 1.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 331,516.00 |
| Dec 31, 2022 | 331,516.00 |